Federal Register / Vol. 74, No. 170 / Thursday, September 3, 2009 / Notices 45643 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: August 26, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–21290 Filed 9–2–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff, 

Announces the Following Meeting 

Name: ICD–9–CM Coordination and 

Maintenance Committee meeting. 

Time and Date: 9 a.m.–4 p.m., September 

16–17, 2009. 

Place: Centers for Medicare and Medicaid 

Services (CMS) Auditorium, 7500 Security 

Boulevard, Baltimore, Maryland. 

Status: Open to the public. 

Purpose: The ICD–9–CM Coordination and 

Maintenance (C&M) Committee will hold its 

second annual meeting of the 2009 calendar 

year cycle on Wednesday and Thursday 

September 16–17, 2009. The C&M meeting is 

a public forum for the presentation of 

proposed modifications to the International 

Classification of Diseases, Ninth-Revision, 

Clinical Modification. There will be 200 

telephone lines available from 9 a.m. until 4 

p.m. (both days) for those who are unable to 

attend the meeting in person. The toll-free 

dial-in number for external participants is 

1–877–267–1577; participant code is 974574. 

Participants attending by telephone do not 

need to formally register for the meeting. 

Dial-in lines are available on a first come, 

first served basis. 

Matters To Be Discussed: Tentative agenda 

items include: 

September 16, 2009 

ICD–10/MS–DRG update (September 16, 

9–11 a.m.) *Please see list of questions included in 

this notice. 

Insertion of drug-eluting stent into 

superficial femoral artery. 

Circulatory support devices. 

Application of lung sealant. 

Bronchoscopic bronchial thermoplasty. 

Reverse shoulder arthroplasty. 

Implantation of antibiotic matrix. 

Insertion of hemodynamic monitoring 

system. 

Implantatation of carotid sinus activation 

device. 

Addenda (procedures). 

September 17, 2009 

Acquired absence of pancreas. 

Adverse reactions to blood products. 

Cognitive symptoms related to Traumatic 

Brain Injury (TBI) and other neurological 

conditions. 

Do not resuscitate (DNR). 

Heart failure. 

IUD surveillance. 

Mesh exposure. 

Multiple sclerosis expansion. 

Neurofibromatosis. 

Neurogenic claudication. 

Pickwickian syndrome. 

Physical restraints. 

Stuttering. 

Addenda (diagnoses). 

Request for Input From Interested 

Stakeholders Regarding the Freezing of ICD– 

9–CM and ICD–10–CM/ICD–10–PCS and 

Related Issues 

The ICD–9–CM Coordination and 

Maintenance Committee is interested in 

obtaining input on any or all of the following 

issues: 

1. Should ICD–9–CM updates be frozen 

prior to the October 1, 2013 implementation 

of ICD–10–CM and ICD–10–PCS? 

(a) If yes, should the last update to ICD– 

9–CM be effective October 1, 2011 (FY 2012) 

or October 1, 2012 (FY 2013)? 

(b) What is the advantage of this date? 

(c) What is the disadvantage(s) of freezing 

the update process? 

(d) Do you have any other comments 

related to freezing the ICD–9–CM 

classification? 

2. Should ICD–10–CM and ICD–10–PCS be 

frozen prior to the October 1, 2013 

implementation of ICD–10–CM and ICD–10– 

PCS? 

(a) If yes, what should be the last update 

to ICD–10–CM and ICD–10–PCS (FY2012 or 

FY2013)? 

(b) What is the advantage(s) of this date? 

(c) What is the disadvantage(s) of freezing 

the update process? 

(d) Do you have any other comments 

related to freezing the ICD–10–CM and ICD– 

10–PCS classifications? 

3. At what point should the updating of 

ICD–10–CM and ICD–10–PCS begin again 

(e.g., October 1, 2014 (FY 2015)? 

(a) What is the advantage of this date? 

(b) Do you have any other comments 

related to re-starting the updating process for 

ICD–10–CM and ICD–10–PCS? 

4. What ICD–10 coding products are 

vendors developing (e.g., ICD–10–CM and 

ICD–10–PCS code books, encoders, 

automated mapping applications based on 

the General Equivalence Mappings)? 

5. Currently the CMS abbreviated code 

titles are limited to 24 characters. With the 

longer ICD–10–CM and ICD–10–PCS code 

titles, should consideration be given to 

expanding these codes titles? If so, how long 

should the ICD–10-based titles be? 

The ICD–9–CM Coordination and 

Maintenance Committee plans to hear 

comments on these issues at the September 

16, 2009 meeting (9–11 a.m.). We encourage 

you to attend the meeting and provide these 

comments and/or to submit written 

comments on the above issues to Pat Brooks 

(patricia.brooks2@cms.hhs.gov and Donna 

Pickett (dfp4@cdc.gov). 

Contact Person for Additional Information: 

Amy Blum, Medical Systems Specialist, 

Classifications and Public Health Data 

Standards Staff, NCHS, 3311 Toledo Road, 

Room 2402, Hyattsville, Maryland 20782, email alb8@cdc.gov, telephone 301–458–4106 

(diagnosis), Mady Hue, Health Insurance 

Specialist, Division of Acute Care, CMS, 7500 

Security Blvd., Baltimore, Maryland, 21244, 

e-mail marilu.hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). 

Notice: Because of increased security 

requirements CMS has instituted stringent 

procedures for entrance into the building by 

non-government employees. Persons without 

a government I.D. will need to show an 

official form of picture I.D., (such as a drivers 

license), and sign-in at the security desk 

upon entering the building. 

Those who wish to attend a specific ICD– 

9–CM C&M meeting in the CMS auditorium 

must submit their name and organization for 

addition to the meeting visitor list. Those 

wishing to attend the September 16–17, 2009 

meeting must submit their name and 

organization by September 10, 2009 for 

inclusion on the visitor list. This visitor list 

will be maintained at the front desk of the 

CMS building and used by the guards to 

admit visitors to the meeting. Those who 

attended previous ICD–9–CM C&M meetings 

will no longer be automatically added to the 

visitor list. You must request inclusion of 

your name prior to each meeting you attend. 

Register to attend the meeting on-line at: 

http://www.cms.hhs.gov/apps/events/. 

Participants attending by telephone do not 

need to formally register for the meeting. 

Notice: This is a public meeting. However, 

because of fire code requirements, should the 

number of attendants meet the capacity of the 

room, the meeting will be closed. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: August 26, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–21288 Filed 9–2–09; 8:45 am] 

BILLING CODE 4160–18–P 


pwalker on DSK8KYBLC1PROD with NOTICES